Status:

COMPLETED

Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin

Lead Sponsor:

Seoul National University Hospital

Conditions:

Diabetes Mellitus

Eligibility:

MALE

20-50 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to investigate the pharmacokinetics and pharmacodynamics of sitagliptin in healthy volunteers.

Eligibility Criteria

Inclusion

  • Healthy male subjects aged 20 - 50 years
  • A body mass index (BMI) in the range 17-28 kg/m2
  • Fasting plasma glucose levels in the range 70-110 mg/dL
  • Sufficient ability to understand the nature of the study and any hazards of participating in it
  • Provide written informed consent after being fully informed about the study procedures

Exclusion

  • Presence or history of severe adverse reaction to any drug (e.g., sitagliptin) or a history of severe allergic disease
  • Clinically relevant abnormal medical history that could interfere with the objectives of the study
  • A subject who has the following screening laboratory test results; creatinine clearance (calculated by Cockcroft-Gault equation) \< 80 mL/min
  • History of gastrointestinal disease or surgery (except simple appendectomy or repair of hernia), which can influence the absorption of the study drug
  • A subject whose SBP is over 150 mmHg or below 100 mmHg and DBP is over 95 mmHg or below 65 mmHg
  • Presence or history of drug abuse
  • Participation in other clinical trial within 2 months
  • Use of a prescription medicine, herbal medicine within 2 weeks or over-the-counter medication within 1 week before first dose
  • Blood donation during 2 months or apheresis during 1 month before the study
  • Presence or history of alcohol abuse
  • Users of nicotine-containing substances within the previous three months
  • Use of grapefruit juice, alcohol or smoking during restriction period
  • Subject judged not eligible for study participation by investigator

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00960453

Start Date

December 1 2008

Last Update

February 23 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Trials Center; Seoul National University Hospital

Seoul, South Korea, 110-744

Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin | DecenTrialz